{"id":30016,"date":"2014-09-02T09:31:46","date_gmt":"2014-09-02T13:31:46","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=30016"},"modified":"2014-09-02T09:31:46","modified_gmt":"2014-09-02T13:31:46","slug":"general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016","title":{"rendered":"General Electric Company (NYSE:GE)\u2019s GE Healthcare Receives EU Approval For VIZAMYL\u2122 Marketing For Alzheimer\u2019s And Cognitive Impairment Diagnostics"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 09\/02\/2014 (wallstreetpr) \u2013 GE Healthcare, a division of <strong>General Electric Company (NYSE:GE)<\/strong>, recently made an announcement that the European Commission gave its nod for marketing of <a href=\"http:\/\/finance.yahoo.com\/news\/ge-healthcare-announces-european-union-070000101.html\" target=\"_blank\"><strong>VIZAMYL\u2122<\/strong><\/a>, a flutemetamol (<sup>18<\/sup>F) solution for injection. The European Commission gave marketing authorisation for VIZAMYL\u2122 as the radio-pharmaceutical medicinal merchandise, which has been directed for use of Positron Emission Tomography Imaging in brains of adult patients suffering from Alzheimer\u2019s disease (AD).<\/p>\n<p style=\"text-align: justify;\"><strong>European Commission\u2019s Nod for VIZAMYL\u2122 in AD<\/strong><\/p>\n<p style=\"text-align: justify;\">VIZAMYL\u2122 shall be used or directed towards PET imaging of especially beta amyloid neuritic plaque density in patients\u2019 brains. The patients having cognitive impairment and being evaluated for AD along with other kinds of cognitive impairments shall be eligible for this.<\/p>\n<p style=\"text-align: justify;\">It must be noted that VIZAMYL\u2122 is an only PET imaging tracer used to detect amyloid, being given approval in Europe for colored images&#8217; interpretation. It shall be available in a few European countries on a commercial basis starting 2015. VIZAMYL\u2122 is primarily a diagnostic instrument and needs to be used along with clinical evaluation as well.<\/p>\n<p style=\"text-align: justify;\"><strong>Statement from GE Healthcare<\/strong><\/p>\n<p style=\"text-align: justify;\">The President and CEO of Life Sciences, <strong>General Electric Company (NYSE:GE)<\/strong>, <em>Kieran Murphy<\/em> called Dementia as a primary largest health as well as societal challenge across the globe. He added that getting a green signal for marketing authorisation of VIZAMYL\u2122 in the EU would help the company in meeting challenges as well as assisting faster diagnostics of Alzheimer\u2019s disease.<\/p>\n<p style=\"text-align: justify;\">Mr. Murphy also said that the approval shall offer the physicians a crucial tool in the EU in order to find out about the Alzheimer\u2019s disease in a few patients and at the same time, will also help in enhancing the future research process of disease modification elements.<\/p>\n<p style=\"text-align: justify;\"><strong>Statement from the Alzheimer Center at the VU University Medical Center<\/strong><\/p>\n<p style=\"text-align: justify;\">The Cognitive Neurology Professor as well as the Director, Alzheimer Center situated in VU University Medical Center, Amsterdam, <em>Philip Scheltens<\/em>. Meanwhile said that both dementia, as well as Alzheimer\u2019s disease, are a continuous burden on the society and healthcare, which is why VIZAMYL\u2122 will prove to be important for support, as well as guidance of future research in development of disease modification techniques.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 09\/02\/2014 (wallstreetpr) \u2013 GE Healthcare, a division of General Electric Company (NYSE:GE), recently made an announcement that the European Commission gave its nod [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":7821,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236,263],"tags":[1665,8573,1664,8574],"stock_ticker":[],"class_list":["post-30016","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-technology","tag-general-electric-company-nysege","tag-kieran-murphy","tag-nysege","tag-philip-scheltens","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>General Electric Company (NYSE:GE)\u2019s GE Healthcare Receives EU Approval For VIZAMYL\u2122 Marketing For Alzheimer\u2019s And Cognitive Impairment Diagnostics - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"General Electric Company (NYSE:GE)\u2019s GE Healthcare Receives EU Approval For VIZAMYL\u2122 Marketing For Alzheimer\u2019s And Cognitive Impairment Diagnostics - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 09\/02\/2014 (wallstreetpr) \u2013 GE Healthcare, a division of General Electric Company (NYSE:GE), recently made an announcement that the European Commission gave its nod [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-09-02T13:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/General-Electric-Logo-Wallpapers.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"General Electric Company (NYSE:GE)\u2019s GE Healthcare Receives EU Approval For VIZAMYL\u2122 Marketing For Alzheimer\u2019s And Cognitive Impairment Diagnostics\",\"datePublished\":\"2014-09-02T13:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016\"},\"wordCount\":384,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/General-Electric-Logo-Wallpapers.jpg\",\"keywords\":[\"General Electric Company (NYSE:GE)\",\"Kieran Murphy\",\"NYSE:GE\",\"Philip Scheltens\"],\"articleSection\":[\"Business\",\"Technology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016\",\"name\":\"General Electric Company (NYSE:GE)\u2019s GE Healthcare Receives EU Approval For VIZAMYL\u2122 Marketing For Alzheimer\u2019s And Cognitive Impairment Diagnostics - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/General-Electric-Logo-Wallpapers.jpg\",\"datePublished\":\"2014-09-02T13:31:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/General-Electric-Logo-Wallpapers.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/General-Electric-Logo-Wallpapers.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"General Electric Company (NYSE:GE)\u2019s GE Healthcare Receives EU Approval For VIZAMYL\u2122 Marketing For Alzheimer\u2019s And Cognitive Impairment Diagnostics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"General Electric Company (NYSE:GE)\u2019s GE Healthcare Receives EU Approval For VIZAMYL\u2122 Marketing For Alzheimer\u2019s And Cognitive Impairment Diagnostics - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016","og_locale":"en_US","og_type":"article","og_title":"General Electric Company (NYSE:GE)\u2019s GE Healthcare Receives EU Approval For VIZAMYL\u2122 Marketing For Alzheimer\u2019s And Cognitive Impairment Diagnostics - Wall Street PR","og_description":"Boston, MA 09\/02\/2014 (wallstreetpr) \u2013 GE Healthcare, a division of General Electric Company (NYSE:GE), recently made an announcement that the European Commission gave its nod [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-09-02T13:31:46+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/General-Electric-Logo-Wallpapers.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"General Electric Company (NYSE:GE)\u2019s GE Healthcare Receives EU Approval For VIZAMYL\u2122 Marketing For Alzheimer\u2019s And Cognitive Impairment Diagnostics","datePublished":"2014-09-02T13:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016"},"wordCount":384,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/General-Electric-Logo-Wallpapers.jpg","keywords":["General Electric Company (NYSE:GE)","Kieran Murphy","NYSE:GE","Philip Scheltens"],"articleSection":["Business","Technology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016","url":"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016","name":"General Electric Company (NYSE:GE)\u2019s GE Healthcare Receives EU Approval For VIZAMYL\u2122 Marketing For Alzheimer\u2019s And Cognitive Impairment Diagnostics - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/General-Electric-Logo-Wallpapers.jpg","datePublished":"2014-09-02T13:31:46+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/General-Electric-Logo-Wallpapers.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/General-Electric-Logo-Wallpapers.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/general-electric-company-nyseges-ge-healthcare-receives-eu-approval-for-vizamyl-marketing-for-alzheimers-and-cognitive-impairment-diagnostics-30016#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"General Electric Company (NYSE:GE)\u2019s GE Healthcare Receives EU Approval For VIZAMYL\u2122 Marketing For Alzheimer\u2019s And Cognitive Impairment Diagnostics"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/30016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=30016"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/30016\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/7821"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=30016"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=30016"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=30016"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=30016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}